2,2,5-Trimethyl-1,3-dioxane-4,6-dione is used as a reagent in the synthesis of 3',4'-bis-difluoromethoxycinnamoylanthranilate (FT061) which is an orally-active antifibrotic agent that reduces albuminuria in rat models of progressive diabetic nephropathy.
您的位置：
